Meeting
2022 ASCO Annual Meeting
Optimizing supportive care for patients with metastatic lung cancer in the era of precision oncology.
Authors
Kelly Hsu
Massachusetts General Hospital, Boston, MA
Kelly Hsu , Lecia V. Sequist , Vicki A. Jackson , Elyse R. Park , Dustin Rabideau , Joseph A. Greer , Jennifer Temel , Laura A Petrillo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT04900935
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS12150)
DOI
10.1200/JCO.2022.40.16_suppl.TPS12150
Abstract #
TPS12150
Poster Bd #
388a
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Caveat emptor: A descriptive analysis of guideline-recommended biomarker inclusion in targeted NGS panels for metastatic non-small cell lung cancer (mNSCLC).
First Author: John Leonard Fox
Poster
2021 ASCO Annual Meeting
Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
First Author: Shingo Matsumoto
Poster
2020 ASCO Quality Care Symposium
Biomarker testing patterns and use of targeted therapy in Medicare Fee-for-Service (FFS) beneficiaries newly diagnosed with metastatic non-small cell lung cancer (mNSCLC).
First Author: Anik Patel
Poster
2020 ASCO Virtual Scientific Program
Establishment of the first international large-scale, genomic screening platform to identify patients with rare oncogene drivers in non-small cell lung cancer (NSCLC) in East Asia.
First Author: Shingo Matsumoto